Friedreich's Ataxia Clinical Trials

A listing of Friedreich's Ataxia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 96 clinical trials
featured
Longitudinal Gait and Balance Measurement

Longitudinal Gait and Balance Measurement

  • 190 views
  • 23 Nov, 2020
  • 1 location
featured
Pilot Study of a 3d Motion Device- Feasibility Assessment in Patients with Parkinson’s Disease and Friedreich’s Ataxia

Pilot Study of a 3d Motion Device- Feasibility Assessment in Patients with Parkinson’s Disease and Friedreich’s Ataxia

  • 160 views
  • 23 Nov, 2020
  • 1 location
A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

The primary objective of the study is to evaluate the efficacy (using the modified Friedreich Ataxia Rating Scale [mFARS]) and safety of vatiquinone in participants with Friedreich ataxia (FA

  • 0 views
  • 03 Jul, 2021
  • 14 locations
The HOME Study (HPN With OMEGA-3)

The aim of the trial is to investigate safety and tolerability of an Omega-3-FA-enriched lipid emulsion in adult patients with chronic intestinal failure in need of long-term HPN. It is aimed to

  • 15 views
  • 03 Feb, 2021
  • 13 locations
NAD+ Precursor Supplementation in Friedreich's Ataxia

The primary objective is to test the safety and tolerability of short-term therapy with a nicotinamide adenine dinucleotide (NAD+) precursor (MIB-626) in adults with Friedreich's Ataxia (FA

  • 0 views
  • 31 Mar, 2021
  • 1 location
NAD+ and Exercise in FA

Randomized, placebo-controlled trial with a 2x2 factorial design testing the effects of an NAD+ precursor (NR) and exercise on VO2max and Si in Friedreich's Ataxia (FA). The primary

  • 8 views
  • 27 Jan, 2021
  • 1 location
Micronised Resveratrol as a Treatment for Friedreich Ataxia

The aim of this study is to assess the efficacy of micronised resveratrol as a treatment for FRDA, in terms of reducing the severity of ataxia symptoms at 24 weeks, through a randomised blinded

resveratrol
neutrophils
total bilirubin
  • 196 views
  • 04 Mar, 2021
  • 4 locations
Safety and Efficacy of Etravirine in Friedreich Ataxia Patients

treatment for FA. We found that Etravirine is able to increase Frataxin protein both in vitro - in cells derived from FA patients - and in vivo - in the heart and skeletal muscle of Frataxin-deficient YG8

  • 0 views
  • 27 Jan, 2021
  • 1 location
Coronary Artery Disease in Patients With Friedreich's Ataxia

clusters, molecules that are essential for energy production in our cells as well as repair of our genetic code embedded in DNA molecules. Friedreich's ataxia (FRDA) and deficiency of FXN results in a

  • 0 views
  • 22 Feb, 2021
  • 1 location
Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients

Friedreich's Ataxia (FA) is an autosomal recessive disease the mutation of which leads to a deficiency of a protein called frataxin, which is responsible for the symptoms of the disease. It is

deficiency
point mutation
  • 0 views
  • 26 Jun, 2021
  • 1 location